Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial

Ameri, A; Asadi, MF; Ziaei, A; Vatankhah, M; Safa, O; Kamali, M; Fathalipour, M; Mahmoodi, M; Hassanipour, S

Kamali, M (通讯作者)，Hormozgan Univ Med Sci, Anesthesiol Crit Care & Pain Management Res Ctr, Bandar Abbas, Iran.;Kamali, M (通讯作者)，Hormozgan Univ Med Sci, Infect & Trop Dis Res Ctr, Hormozgan Hlth Inst, Bandar Abbas, Iran.;Fathalipour, M (通讯作者)，Hormozgan Univ Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Bandar Abbas, Iran.;Fathalipour, M (通讯作者)，Hormozgan Univ Med Sci, Endocrinol & Metab Res Ctr, Bandar Abbas, Iran.

INFLAMMOPHARMACOLOGY, 2023; 31 (1): 265

Abstract

Patients with COVID-19 have shown melatonin deficiency. We evaluated the efficacy and safety of administration oral melatonin in patients with COVID-1......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索